Optimal dose of rituximab in ABO-incompatible kidney transplantation in patients with low anti-A/B antibody titers: a single-center retrospective cohort study.
Manabu OkadaShunji NarumiYuki HasegawaKenta FutamuraTakahisa HiramitsuToshihiro IchimoriNorihiko GotoTakaaki KobayashiKazuharu UchidaAsami TakedaYoshihiko WataraiPublished in: Clinical transplantation (2023)
In ABOi kidney transplantation patients with low anti-A/B antibody titers, the desensitization protocol with a single dose of 100 mg rituximab was effective in preventing acute AMR without increasing the risk of other adverse events. This article is protected by copyright. All rights reserved.